RTW Biotech Opportunities (LON:RTW – Get Free Report) reached a new 52-week high during mid-day trading on Thursday . The company traded as high as GBX 1.88 and last traded at GBX 1.88, with a volume of 606103 shares traded. The stock had previously closed at GBX 1.87.
RTW Biotech Opportunities Stock Up 0.5%
The firm’s 50-day moving average is GBX 1.66 and its 200-day moving average is GBX 1.41. The company has a market capitalization of £6.14 million, a PE ratio of -0.07 and a beta of 0.60.
About RTW Biotech Opportunities
RTW Biotech Opportunities Ltd (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Bio invests in companies developing next-generation therapies and technologies that can significantly improve patients’ lives.
See Also
- Five stocks we like better than RTW Biotech Opportunities
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Datavault AI Just Raised Guidance by 400%—Are You Paying Attention?
- Growth Stocks: What They Are, What They Are Not
- Peter Thiel Dumps NVIDIA and Slashes Tesla Stake—Is the AI Bubble About to Pop?
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Why Lithium Americas Could Be a 2030 Power Play—Not a 2025 One
Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.
